Why Is Legend Biotech Stock Falling Thursday?

Legend Biotech Corp. (NASDAQ:LEGN) stock fell in Thursday’s premarket trading after the cell therapy company priced an underwritten public offering of 7.7 million American Depositary Shares (ADSs) at $29.35 per ADS. The offering is expected to raise about $226 million...